Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Net Income (2020 - 2025)

BioAtla's Net Income history spans 6 years, with the latest figure at -$9.2 million for Q4 2025.

  • For Q4 2025, Net Income rose 41.48% year-over-year to -$9.2 million; the TTM value through Dec 2025 reached -$58.5 million, up 17.16%, while the annual FY2025 figure was -$58.5 million, 17.16% up from the prior year.
  • Net Income reached -$9.2 million in Q4 2025 per BCAB's latest filing, up from -$13.7 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$9.2 million in Q4 2025 to a low of -$35.7 million in Q2 2023.
  • Average Net Income over 5 years is -$22.8 million, with a median of -$23.5 million recorded in 2021.
  • Peak YoY movement for Net Income: crashed 1508.0% in 2021, then skyrocketed 68.22% in 2024.
  • A 5-year view of Net Income shows it stood at -$23.4 million in 2021, then decreased by 17.62% to -$27.5 million in 2022, then rose by 2.24% to -$26.9 million in 2023, then soared by 41.67% to -$15.7 million in 2024, then surged by 41.48% to -$9.2 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Net Income are -$9.2 million (Q4 2025), -$13.7 million (Q3 2025), and -$18.4 million (Q2 2025).